The target cells of injected type I interferons in mouse liver

被引:4
|
作者
Asada-Kubota, M [1 ]
Tatsumi, R [1 ]
Ueda, T [1 ]
Kobayashi, M [1 ]
Hamada, K [1 ]
Maekawa, S [1 ]
Sokawa, Y [1 ]
机构
[1] Kyoto Inst Technol, Dept Biotechnol, Sakyo Ku, Kyoto 606, Japan
来源
关键词
D O I
10.1089/jir.1998.18.71
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type I interferons (IFNs) have been used for the treatment of viral hepatitis, but it is unclear which cells in the liver are affected by injected IFN, The effects of IFN have been studied by the production of 2',5'-oligoadenylate synthetase (2'5'OAS), an IFN-inducible enzyme, Here, we studied the distribution of 2'5'OAS in mouse liver after injection of natural mouse IFN-alpha/beta by Western blotting and immunohistochemistry using a monoclonal antibody specific to mouse 42-kDa 2'5'OAS, Injection of IFN-alpha/beta increased the levels of liver 2'5'OAS and enhanced the intensities of immunohistochemical staining for this enzyme in both hepatocytes and Kupffer cells, In IFN-untreated normal mice, hepatocytes were lightly stained, but some of the Kupffer cells showed rather strong staining, The 2'5'OAS-positive Kupffer cells comprised similar to 60% of those in normal liver, whereas this increased to similar to 90% following IFN-alpha/beta injection, Thus, hepatocytes and Kupffer cells were the targets of injected IFN.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [31] Type I interferons: expression and signalization
    J. Doly
    A. Civas
    S. Navarro
    G. Uze
    Cellular and Molecular Life Sciences CMLS, 1998, 54 : 1109 - 1121
  • [32] Overview of the biology of type I interferons
    Kalliolias, George D.
    Ivashkiv, Lionel B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12
  • [33] Type I interferons in anticancer immunity
    Zitvogel, Laurence
    Galluzzi, Lorenzo
    Kepp, Oliver
    Smyth, Mark J.
    Kroemer, Guido
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (07) : 405 - 414
  • [34] Signal transduction by type I interferons
    David, M
    BIOTECHNIQUES, 2002, : 58 - 65
  • [35] Type I Interferons in Autoimmune Disease
    Crow, Mary K.
    Olferiev, Mikhail
    Kirou, Kyriakos A.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14, 2019, 14 : 369 - 393
  • [36] Effects of type I interferons in malaria
    Sebina, Ismail
    Haque, Ashraful
    IMMUNOLOGY, 2018, 155 (02) : 176 - 185
  • [37] Type I interferons: expression and signalization
    Doly, J
    Civas, A
    Navarro, S
    Uze, G
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (10) : 1109 - 1121
  • [38] Type I interferons in anticancer immunity
    Laurence Zitvogel
    Lorenzo Galluzzi
    Oliver Kepp
    Mark J. Smyth
    Guido Kroemer
    Nature Reviews Immunology, 2015, 15 : 405 - 414
  • [39] Immunomodulatory functions of type I interferons
    José M. González-Navajas
    Jongdae Lee
    Michael David
    Eyal Raz
    Nature Reviews Immunology, 2012, 12 : 125 - 135
  • [40] Type-I interferons in atherosclerosis
    Chen, Hung-Jen
    Tas, Sander W.
    de Winther, Menno P. J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (01):